Doctor profile · Federal record
Dr. SCOTT SANDERS, M.D.
Dermatopathology Physician (CMS: DERMATOLOGY) · NEW CITY, NY
- NPI 1780670927
- Accepts Medicare
- MIPS 68.5 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
301 N MAIN ST, SUITE 3
NEW CITY, NY 109564021
(845) 499-2017
fax (845) 499-2018
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- February 18, 2016
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207ND0900X — NUCC code
- State license (1)
- New York #218276
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780670927. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,490
Distinct HCPCS
10
Medicare allowed
$1,649,159
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,736 | 642 | $8 | |
J3245 |
Injection, tildrakizumab, 1 mg | 3,200 | 11 | $135 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,834 | 1,806 | $105 | |
95044 |
Test for allergy using skin patch | 1,851 | 24 | $6 | |
96920 |
Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 1,141 | 38 | $181 | |
17000 |
Destruction of precancer skin growth, 1 growth | 998 | 818 | $55 | |
17110 |
Destruction of skin growth, 1-14 growths | 984 | 847 | $131 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 878 | 29 | $143 | |
11102 |
Biopsy of related skin growth, first growth | 651 | 568 | $99 | |
96921 |
Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 416 | 20 | $203 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 711. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$6,606
Transactions
353
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 46 | $758.12 | |
| Janssen Biotech, Inc. | 39 | $710.70 | |
| Dermavant Sciences, Inc. | 65 | $640.21 | |
| PFIZER INC. | 32 | $558.93 | |
| UCB, Inc. | 20 | $482.08 | |
| Lilly USA, LLC | 20 | $449.86 | |
| E.R. Squibb & Sons, L.L.C. | 22 | $418.53 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $343.22 | |
| GENZYME CORPORATION | 12 | $323.55 | |
| Regeneron Healthcare Solutions, Inc. | 12 | $313.97 | |
| Incyte Corporation | 13 | $310.53 | |
| Amgen Inc. | 9 | $242.32 | |
| Blueprint Medicines Corporation | 4 | $209.10 | |
| Galderma Laboratories, L.P. | 23 | $207.31 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 17 | $157.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,371
Patients
1,397
Total drug cost
$806,346
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 312 | 228 | $3,587 |
| Clobetasol Propionate | Generic | 305 | 184 | $14,542 |
| Ketoconazole | Generic | 263 | 122 | $5,388 |
| Mupirocin | Generic | 236 | 166 | $2,008 |
| Hydrocortisone | Generic | 216 | 141 | $1,366 |
| Dupixent Syringe (Dupilumab) | Brand | 159 | 22 | $709,685 |
| Halobetasol Propionate | Generic | 131 | 72 | $7,977 |
| Fluorouracil | Generic | 120 | 105 | $9,696 |
| Metronidazole | Generic | 116 | 59 | $8,899 |
| Nystatin | Generic | 101 | 68 | $1,533 |